A study using a new imaging agent for multiple myeloma
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study tests a new imaging agent that may help doctors see multiple myeloma more clearly. It uses a special radioactive tracer that targets a protein found on myeloma cells, which could improve diagnosis and monitoring of the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have newly diagnosed or relapsed multiple myeloma.
- You are willing and able to give written informed consent and attend follow-up visits.
- You do not have severe liver or kidney problems.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study period.
- You can lie flat for 30 minutes.
- You do not have claustrophobia or other conditions that would prevent you from cooperating with the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new imaging agent called 68Ga-NOTA-SCH001 to see if it can help detect multiple myeloma. It also looks at how safe the agent is and how it spreads in the body.
This study uses a special PET/MR scan with a tracer called 68Ga-Pentixafor to see if it can better find lymphoma and multiple myeloma spots in the body. It may help doctors get clearer pictures than standard scans.
This study uses advanced imaging (PET-CT scans) to help doctors better see multiple myeloma in patients who are about to receive CAR T-cell therapy. The goal is to improve how doctors detect and monitor the cancer using a newer type of scan.
This trial tests a new type of PET scan that uses a radioactive tracer (68Ga-BCMA) to find active multiple myeloma cells in your body. It may help doctors better detect and monitor the disease.
This trial tests a special imaging dye that targets a protein called BCMA on multiple myeloma cells. It may help doctors see and diagnose the disease more clearly during bone marrow or tissue biopsies.
This study uses a special PET scan to look for multiple myeloma in your body. It may help doctors see where the disease is and how active it is.
Hear when a new Multiple Myeloma (MM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.